Effective elicitation of human effector CD8+ T cells in HLA-B*51:01 transgenic humanized mice after infection with HIV-1

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Sato, Yoshinori ^a   Nagata, Sayaka ^a   Takiguchi, Masafumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR1; HLA B ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HIV-1; HLA-B51 ANTIGEN; HUMANS; JANUS KINASE 3; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; PHENOTYPE; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN-8A;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MUS;

EID: 84864646832     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042776     Document Type: Article

References (66)

1. Hiramatsu H, Nishikomori R, Heike T, Ito M, Kobayashi K, et al. ((2003)) Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/γcnull mice model. Blood 102: 873-880.
2. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, et al. ((2002)) NOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100: 3175-3182.
3. Matsumura T, Kametani Y, Ando K, Hirano Y, Katano I, et al. ((2003)) Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/γcnull (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells. Exp Hematol 31: 789-797.
4. Watanabe Y, Takahashi T, Okajima A, Shiokawa M, Ishii N, et al. ((2009)) The analysis of the functions of human B and T cells in humanized NOD/shi-scid/γcnull (NOG) mice (hu-HSC NOG mice). Int Immunol 21: 843-858.
5. Yahata T, Ando K, Nakamura Y, Ueyama Y, Shimamura K, et al. ((2002)) Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor γ null mice. J Immunol 169: 204-209.
6. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, et al. ((2005)) Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice. Blood 106: 1565-1573.
7. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, et al. ((2005)) Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174: 6477-6489.
8. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, et al. ((2004)) Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304: 104-7.
9. Legrand N, Weijer K, Spits H, ((2006)) Experimental models to study development and function of the human immune system in vivo. J Immunol 176: 2053-2058.
10. Shultz LD, Ishikawa F, Greiner DL, ((2007)) Humanized mice in translational biomedical research. Nat Rev Immunol 7: 118-130.
11. Ito R, Takahashi T, Katano I, Ito M, ((2012)) Current advances in humanized mouse models. Cell Mol Immunol 9: 208-214.
12. Garcia S, Freitas AA, ((2012)) Humanized mice: Current states and perspectives. Immunol Lett Available online 9 April 2012.
13. Strowig T, Gurer C, Ploss A, Liu YF, Arrey F, et al. ((2009)) Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med 206: 1423-1434.
14. Yajima M, Imadome K, Nakagawa A, Watanabe S, Terashima K, et al. ((2008)) A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J Infect Dis 198: 673-682.
15. Marodon G, Desjardins D, Mercey L, Baillou C, Parent P, et al. ((2009)) High diversity of the immune repertoire in humanized NOD.SCID.γc-/- mice. Eur J Immunol 39: 2136-2145.
16. Sato Y, Takata H, Kobayashi N, Nagata S, Nakagata N, et al. ((2010)) Failure of effector function of human CD8+ T cells in NOD/SCID/JAK3-/- immunodeficient mice transplanted with human CD34+ hematopoietic stem cells. PLoS One 5: e13109.
17. Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, et al. ((2009)) Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol 83: 7305-7321.
18. Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, et al. ((2006)) Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12: 1316-1322.
19. Sun Z, Denton PW, Estes JD, Othieno FA, Wei BL, et al. ((2007)) Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med 204: 705-714.
20. Shultz LD, Saito Y, Najima Y, Tanaka S, Ochi T, et al. ((2010)) Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice. Proc Natl Acad Sci U S A 107: 13022-13027.
21. Jaiswal S, Pearson T, Friberg H, Shultz LD, Greiner DL, et al. ((2009)) Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rγnull mice. PLoS One 4: e7251.
22. Denton PW, García JV, ((2011)) Humanized mouse models of HIV infection. AIDS Rev 13: 135-148.
23. Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R, ((2006)) HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-γc-/- (RAG-hu) mouse model. Retrovirology 3: 76.
24. Berges BK, Akkina SR, Remling L, Akkina R, ((2010)) Humanized Rag2-/-γc-/- (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a year. Virology 5: 100-103.
25. Watanabe S, Ohta S, Yajima M, Terashima K, Ito M, et al. ((2007)) Humanized NOD/SCID/IL2Rγnull mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis. J Virol 81: 13259-13264.
26. Gorantla S, Makarov E, Finke-Dwyer J, Gebhart CL, Domm W, et al. ((2010)) CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice. J Immunol 184: 7082-7091.
27. Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, et al. ((2007)) Hematopoietic stem cell-engrafted NOD/SCID/IL2Rγnull mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 109: 212-218.
28. Jiang Q, Zhang L, Wang R, Jeffrey J, Washburn ML, et al. ((2008)) FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-γC-/- mice in vivo. Blood 112: 2858-2868.
29. Sato K, Izumi T, Misawa N, Kobayashi T, Yamashita Y, et al. ((2010)) Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice. J Virol 84: 9546-9556.
30. Singh M, Singh P, Gaudray G, Musumeci L, Thielen C, et al. ((2012)) An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2RγNULL mice allows HIV replication and development of anti-HIV immune responses. PLoS One 7: e38491.
31. Okada R, Kondo T, Matsuki F, Takata H, Takiguchi M, ((2008)) Phenotypic classification of human CD4+ T cell subsets and their differentiation. Int Immunol 20: 1189-1199.
32. Tomiyama H, Matsuda T, Takiguchi M, ((2002)) Differentiation of human CD8+ T cells from a memory to memory/effector phenotype. J Immunol 168: 5538-5550.
33. Tomiyama H, Takata H, Matsuda T, Takiguchi M, ((2004)) Phenotypic classification of human CD8+ T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function. Eur J Immunol 34: 999-1010.
34. Gasser O, Missiou A, Eken C, Hess C, ((2005)) Human CD8+ T cells store CXCR1 in a distinct intracellular compartment and up-regulate it rapidly to the cell surface upon activation. Blood 106: 18-24.
35. Takata H, Tomiyama H, Fujiwara M, Kobayashi N, Takiguchi M, ((2004)) Cutting edge: Expression of chemokine receptor CXCR1 on human effector CD8+ T cells. J Immunol 173: 2231-2235.
36. Hertoghs KM, Moerland PD, van Stijn A, Remmerswaal EB, Yong SL, et al. ((2010)) Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. J Clin Invest 120: 4077-4090.
37. Hess C, Means TK, Autissier P, Woodberry T, Altfeld M, et al. ((2004)) IL-8 responsiveness defines a subset of CD8 T cells poised to kill. Blood 104: 3463-3471.
38. Nishimura M, Umehara H, Nakayama T, Yoneda O, Hieshima K, et al. ((2002)) Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 168: 6173-6180.
39. Norment AM, Salter RD, Parham P, Engelhard VH, Littman DR, ((1988)) Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 336: 79-81.
40. Salter RD, Benjamin RJ, Wesley PK, Buxton SE, Garrett TP, et al. ((1990)) A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2. Nature 345: 41-46.
41. Teitell M, Holcombe H, Cheroutre H, Aldrich CJ, Stroynowski I, et al. ((1993)) The α3 domain of the Qa-2 molecule is defective for CD8 binding and cytotoxic T lymphocyte activation. J Exp Med 178: 2139-2145.
42. LaFace DM, Vestberg M, Yang Y, Srivastava R, DiSanto J, et al. ((1995)) Human CD8 transgene regulation of HLA recognition by murine T cells. J Exp Med 182: 1315-1325.
43. Newberg MH, Ridge JP, Vining DR, Salter RD, Engelhard VH, ((1992)) Species specificity in the interaction of CD8 with the α3 domain of MHC class I molecules. J Immunol 149: 136-142.
44. Takata H, Takiguchi M, ((2006)) Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules. J Immunol 177: 4330-4340.
45. Pham HP, Manuel M, Petit N, Klatzmann D, Cohen-Kaminsky S, et al. ((2012)) Half of the T-cell repertoire combinatorial diversity is genetically determined in humans and humanized mice. Eur J Immunol 42: 760-770.
46. Nesić D, Vukmanović S, ((1998)) MHC class I is required for peripheral accumulation of CD8+ thymic emigrants. J Immunol 160: 3705-3712.
47. Middleton D, Menchaca L, Rood H, Komerofsky R, ((2003)) New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 61: 403-407.
48. Nauta AJ, Kruisselbrink AB, Lurvink E, Mulder A, Claas FH, et al. ((2005)) Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit. Exp Hematol 33: 1249-1256.
49. Amir AL, D'Orsogna LJ, Roelen DL, van Loenen MM, Hagedoorn RS, et al. ((2010)) Allo-HLA reactivity of virus-specific memory T cells is common. Blood 115: 3146-3157.
50. Melenhorst JJ, Leen AM, Bollard CM, Quigley MF, Price DA, et al. ((2010)) Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects. Blood 116: 4700-4702.
51. Broudy VC, ((1997)) Stem cell factor and hematopoiesis. Blood 90: 1345-1364.
52. Kameyama Y, Inouye M, ((1994)) Irradiation injury to the developing nervous system: mechanisms of neuronal injury. Neurotoxicology 15: 75-80.
53. Brehm MA, Racki WJ, Leif J, Burzenski L, Hosur V, et al. ((2012)) Engraftment of human HSC in non-irradiated newborn NOD-scid IL2rγnull mice is enhanced by transgenic expression of membrane-bound human SCF. Blood 119: 2778-2788.
54. Wils EJ, Rombouts EJ, van Mourik I, Spits H, Legrand N, et al. ((2012)) Stem cell factor consistently improves thymopoiesis after experimental transplantation of murine or human hematopoietic stem cells in immunodeficient mice. J Immunol 187: 2974-2981.
55. Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, et al. ((2009)) HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 15: 893-900.
56. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D, ((1998)) HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391: 397-401.
57. Tomiyama H, Akari H, Adachi A, Takiguchi M, ((2002)) Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8+ T-cell cytolytic activity and cytokine production. J Virol 76: 7535-7543.
58. Tomiyama H, Fujiwara M, Oka S, Takiguchi M, ((2005)) Cutting edge: Epitope-dependent effect of Nef-mediated HLA class I down-regulation on ability of HIV-1-specific CTLs to suppress HIV-1 replication. J Immunol 174: 36-40.
59. Appay V, Papagno L, Spina CA, Hansasuta P, King A, et al. ((2002)) Dynamics of T cell responses in HIV infection. J Immunol 168: 3660-3666.
60. Combadière B, Faure S, Autran B, Debré P, Combadière C, ((2003)) The chemokine receptor CX3CR1 controls homing and anti-viral potencies of CD8 effector-memory T lymphocytes in HIV-infected patients. AIDS 17: 1279-1290.
61. Nie C, Sato K, Misawa N, Kitayama H, Fujino H, et al. ((2009)) Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rγnull mice. Virology 394: 64-72.
62. Boyman O, Létourneau S, Krieg C, Sprent J, ((2009)) Homeostatic proliferation and survival of naïve and memory T cells. Eur J Immunol 39: 2088-2094.
63. Rochman Y, Spolski R, Leonard WJ, ((2009)) New insights into the regulation of T cells by γc family cytokines. Nat Rev Immunol 9: 480-490.
64. Eisenman J, Ahdieh M, Beers C, Brasel K, Kennedy MK, et al. ((2002)) Interleukin-15 interactions with interleukin-15 receptor complexes: characterization and species specificity. Cytokine 20: 121-129.
65. Karaki S, Kariyone A, Kato N, Kano K, Iwakura Y, et al. ((1993)) HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A, B-specific antibodies. Immunogenetics 37: 139-142.
66. Hachiya A, Aizawa-Matsuoka S, Tanaka M, Takahashi Y, Ida S, et al. ((2001)) Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4+ cell clone 1-10 (MAGIC-5). Antimicrob Agents Chemother 45: 495-501.